GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Witness history! 26 trillion! Is the technology stock frenzy still behind?
Super elephant dancing!
Jinglin's Q3 positions are out: selling microsoft, nvidia, adding 0.59 million shares of apple.
①The well-known Chinese private equity firm Jinglin Assets' Q3 holding value in the US stock market decreased to $3.15 billion, down from $3.79 billion; ②Jinglin Assets' Q3 reduced all of its top ten holdings, cleared multiple technology and pharmaceutical concept stocks, and the largest increase was 0.591 million shares of Apple Inc.
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Amgen, AstraZeneca Post Phase 3 Win for Nasal Polyps Therapy
"Trump trade" fizzled out, what is the market worried about?
The market is concerned that if Trump really fulfills his campaign promises, especially on tariff policy, the usa may see larger deficits and soaring inflation, immigrant workers being deported, which could lead to a significant decline in economic growth.
Market doubts policy difficult to implement, traders' enthusiasm for the "Trump trade" cools down.
After initially rushing into the 'Trump trade', some investors in certain asset classes are gradually lowering their enthusiasm, as they question whether Trump will pursue his ambitious tariff proposals as the President of the USA.